カテゴリ： MarketLine, 企業調査, 日本

Taisho Pharmaceutical Holdings Co Ltd：戦略・SWOT・企業財務分析

◆英語タイトル：Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015717
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：33
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Taisho Pharmaceutical Holdings Co Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Taisho Pharmaceutical Holdings Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Taisho Pharmaceutical Holdings Co Ltd (Taisho Pharmaceutical) is a pharmaceutical company. The company is involved in the development, manufacture and marketing of various pharmaceutical products. The company’s products include self-medication drugs and prescription pharmaceutical. Its self-medication products are marketed under the brand names, including pabron, lipovitan D, riup, livita, naron, colac, zena and among others. Self-Medication also offers real estate leasing, facility management and hotel management services. The company also offer products under the brand names such as include zosyn, clarith, edirol, palux, ozex, geninax, lorcam, pentcillin, tomiron and among others. The company sells macrolide antibiotic clarith through Abbott Laboratories in the US. It distributes products through its subsidiaries located in the Philippines, Indonesia, Malaysia, Thailand, Vietnam, China, Hong Kong, Taiwan, and the US. Taisho Pharmaceutical is headquartered in Tokyo, Japan.

Scope

- Detailed information on Taisho Pharmaceutical Holdings Co Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Taisho Pharmaceutical Holdings Co Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Taisho Pharmaceutical Holdings Co Ltd including a breakdown and examination of key business segments
- Intelligence on Taisho Pharmaceutical Holdings Co Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Taisho Pharmaceutical Holdings Co Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Taisho Pharmaceutical Holdings Co Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Taisho Pharmaceutical Holdings Co Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Taisho Pharmaceutical Holdings Co Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Taisho Pharmaceutical Holdings Co Ltd: Company Overview
Taisho Pharmaceutical Holdings Co Ltd: Overview and Key Facts
Taisho Pharmaceutical Holdings Co Ltd: Overview
Taisho Pharmaceutical Holdings Co Ltd: Key Facts
Taisho Pharmaceutical Holdings Co Ltd: Key Employees
Taisho Pharmaceutical Holdings Co Ltd: Key Employee Biographies
Taisho Pharmaceutical Holdings Co Ltd: Major Products and Services
Taisho Pharmaceutical Holdings Co Ltd: Company History
Taisho Pharmaceutical Holdings Co Ltd: Management Statement
Taisho Pharmaceutical Holdings Co Ltd: Locations and Subsidiaries
Taisho Pharmaceutical Holdings Co Ltd: Key Competitors
Taisho Pharmaceutical Holdings Co Ltd: Company Analysis
Taisho Pharmaceutical Holdings Co Ltd: Business Description
Taisho Pharmaceutical Holdings Co Ltd: SWOT Analysis
Taisho Pharmaceutical Holdings Co Ltd: SWOT Overview
Taisho Pharmaceutical Holdings Co Ltd: Strengths
Taisho Pharmaceutical Holdings Co Ltd: Weaknesses
Taisho Pharmaceutical Holdings Co Ltd: Opportunities
Taisho Pharmaceutical Holdings Co Ltd: Threats
Taisho Pharmaceutical Holdings Co Ltd: Corporate Financial Deals Activity
Taisho Pharmaceutical Holdings Co Ltd: Financial Deals Overview
Taisho Pharmaceutical Holdings Co Ltd: Targets and Partners
Taisho Pharmaceutical Holdings Co Ltd: Top Deals 2013 – 2017YTD*
Taisho Pharmaceutical Holdings Co Ltd: Mergers and Acquisitions
Taisho Pharmaceutical Holdings Co Ltd: Partnership
Taisho Pharmaceutical Holdings Co Ltd: Recent Developments
Taisho Pharmaceutical Holdings Co Ltd: News and Events Summary
Taisho Pharmaceutical Holdings Co Ltd: Regulatory and Legal Events
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Taisho Pharmaceutical Holdings Co Ltd: Key Facts
Table 2: Taisho Pharmaceutical Holdings Co Ltd: Key Employees
Table 3: Taisho Pharmaceutical Holdings Co Ltd: Locations and Subsidiaries
Table 4: Taisho Pharmaceutical Holdings Co Ltd: Key Competitors
Table 5: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Taisho Pharmaceutical Holdings Co Ltd: M&A Average Deal Size - Value (US$m)
Table 7: Taisho Pharmaceutical Holdings Co Ltd: Targets and Partners
Table 8: Taisho Pharmaceutical Holdings Co Ltd: Top Deals 2013 - 2017YTD*
Table 9: Taisho Pharmaceutical Holdings Co Ltd: M&A Volume and Value Trend (2013 - YTD*2017)
Table 10: Taisho Pharmaceutical Holdings Co Ltd: M&A Activity by Geography (2013 - YTD*2017)
Table 11: Taisho Pharmaceutical Holdings Co Ltd: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 12: Taisho Pharmaceutical Holdings Co Ltd: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 13: Taisho Pharmaceutical Holdings Co Ltd: News and Events Summary
Table 14: Taisho Pharmaceutical Holdings Co Ltd: Regulatory and Legal Events

★海外企業調査レポート[Taisho Pharmaceutical Holdings Co Ltd：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Selecta Biosciences Inc (SELB)：製薬・医療：M&Aディール及び事業提携情報
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Coesia S.p.A.：企業の戦略・SWOT・財務情報
    Coesia S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Coesia S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • EnergyHub Inc：企業の戦略的SWOT分析
    EnergyHub Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Wells Fargo Private Bank：企業の戦略・SWOT・財務分析
    Wells Fargo Private Bank - Strategy, SWOT and Corporate Finance Report Summary Wells Fargo Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Foundation for Innovative New Diagnostics-製薬・医療分野：企業M&A・提携分析
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • AirStrip Technologies Inc：医療機器：M&Aディール及び事業提携情報
    Summary AirStrip Technologies Inc (AirStrip) is a healthcare solution provider that offers medical software solutions and services. The company offers mobile interoperability platform interoperability platform that offers access to critical patient data and intelligent insights across the care conti …
  • PFSweb Inc (PFSW)：企業の財務・戦略的SWOT分析
    Summary PFSweb Inc (PFSweb) is an eCommerce solutions provider. Its various services include agency services, marketing services, technology and financial services. The company offers solutions for omnichannel operations, technology ecosystem, and strategic commerce consulting. Its technology ecosys …
  • Cytokinetics Inc (CYTK)-製薬・医療分野：企業M&A・提携分析
    Summary Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases, which compromise muscle performance. The company’s lead drug candidate, tirasemtiv, a fast skeletal muscle troponin activa …
  • Societe Electrique de l’Our SA：企業の戦略的SWOT分析
    Societe Electrique de l'Our SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Carondelet Health Network-製薬・医療分野：企業M&A・提携分析
    Summary Carondelet Health Network (Carondelet) is a healthcare service organization that serves through its network of hospitals including St. Mary’s Hospital, St. Joseph’s Hospital and Holy Cross Hospital. The organization provides a wide range of medical and treatment services such as neurology or …
  • AB Science SA (AB)：製薬・医療：M&Aディール及び事業提携情報
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • Sotera Health LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Sotera Health LLC (Sotera Health), formerly Sterigenics International LLC, a subsidiary of GTCR LLC, is a medical device company. The company offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. Its services include drug device combination, vaccine s …
  • Eurofarma Laboratorios SA：製薬・医療：M&Aディール及び事業提携情報
    Summary Eurofarma Laboratorios SA (Eurofarma), formerly Bill Farmaceutica is a pharmaceutical company that manufactures and markets prescription, generic and veterinary drugs. The company offers prescription products such as aerosol ointment, alprazolam, acebrophylline, altiva, ebastel, fluoruracila …
  • Nobel Biocare Services AG：企業の戦略的SWOT分析
    Nobel Biocare Services AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Enmax Corporation：電力：M&Aディール及び事業提携情報
    Summary ENMAX Corporation (ENMAX), a subsidiary of City of Calgary, is a vertically integrated energy utility. It generates, transmits and distributes electricity; supplies natural gas; and provides value-added services. Through its subsidiaries, the company undertakes deregulated electricity genera …
  • Ur-Energy Inc. (URE)：企業の財務・戦略的SWOT分析
    Ur-Energy Inc. (URE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • HighCom Global Security, Inc.：企業の戦略・SWOT・財務分析
    HighCom Global Security, Inc. - Strategy, SWOT and Corporate Finance Report Summary HighCom Global Security, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Attica Bank S.A.：企業の戦略・SWOT・財務情報
    Attica Bank S.A. - Strategy, SWOT and Corporate Finance Report Summary Attica Bank S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Toyo Tire Corp (5105)：企業の財務・戦略的SWOT分析
    Toyo Tire Corp (5105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Columbia Sportswear Co (COLM)：企業の財務・戦略的SWOT分析
    Columbia Sportswear Co (COLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆